Psychiatry Research and Motherhood at 6 to 8 (PRAM-P@6to8)
PRAM-P@6to8
Do Risk Factors for Postpartum Psychosis Alter Offspring Outcomes in Middle Childhood
1 other identifier
observational
201
1 country
1
Brief Summary
The goal of this observational study is to examine the relationship between severe perinatal maternal mental illness and stress reactivity and general development of children aged 6 to 8 years. Mothers were previously recruited and assessed during pregnancy and their babies were assessed at 6 days, 8 weeks and 12 months post delivery. This follow-up will assess the occurrence of any psychiatric episodes (e.g., depression, mania, psychosis) in the intervening period. Assessments of the children will include evaluation of their response to a mildly stressful procedure, as well as their physical, cognitive and social-emotional development, and their mental health. Possible factors that may moderate the relationship between the mother's perinatal mental health and the child's stress reactivity and development, including the home environment, adversity, parent-child interaction and maternal and paternal (or co-parent) mental health will also be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 27, 2023
CompletedStudy Start
First participant enrolled
November 15, 2023
CompletedFirst Posted
Study publicly available on registry
December 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedSeptember 9, 2025
March 1, 2025
2.1 years
March 27, 2023
September 2, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Child Salivary Cortisol
Child stress response - salivary cortisol: saliva samples will be collected before and after a mild stressor test: Cold Pressor Test (CPT) to assess stress reactivity.
6-8 years
Child Salivary Cortisol
Child stress response - salivary cortisol: saliva samples will be collected before and after a mild stress test: MacArthur Story Stem battery (MSSB) to asses stress reactivity
6-8 years
Secondary Outcomes (13)
Wechsler Intelligence Scale for Children (4th Edition) (WISC-IV)
6-8 years
Wechsler Individual Achievement Test Second UK Edition (WIAT-II UK)
6-8 years
Dimensional Change Card Sort Test (DCCS)
6-8 years
Depression Self-Rating Scale (DSRS)
6-8 years
State-Trait Anxiety Inventory for Children (STAIC)
6-8 years
- +8 more secondary outcomes
Study Arms (2)
Exposed Group
Women at risk of postpartum psychosis during pregnancy
Unexposed Group
Women with no current or past history of psychiatric disorders during pregnancy
Eligibility Criteria
The study comprised 2 groups: women at risk of postpartum psychosis during pregnancy (exposed group) and women with no current or past history of psychiatric disorders (unexposed group). Cases were women at risk of postpartum psychosis because of a DSM-IV diagnosis of bipolar disorder, schizoaffective disorder or previous postpartum psychosis and controls were women who did not have a current or past history of psychiatric disorders. Clinical assessments were undertaken in the second and third trimesters of pregnancy and, following delivery, assessments of mother and infant were undertaken at 6 days, 8 weeks and 12 months post-delivery (n=72). At this stage, participants were asked to provide written consent to be contacted in the future about the possibility of taking part in a follow-up study.
You may qualify if:
- Women who participated in the previous study (Risk factors of perinatal mental disorders: Stress, electrophysiological, and neuroimaging markers), who gave consent to be contacted again, together with their offspring, and the child's father/co-parent.
You may not qualify if:
- Women who participated in the previous study who refused consent to be contacted again.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- King's College Londonlead
- National Institute for Health Research, United Kingdomcollaborator
- Biomedical Research Centrecollaborator
Study Sites (1)
King's College London
London, SE5 8AF, United Kingdom
Biospecimen
Saliva samples from adult participants and their children to assess salivary cortisol. Blood serum is collected from participants for the assessment of inflammatory markers and transcriptomic analysis.
Study Officials
- PRINCIPAL INVESTIGATOR
Paola Dazzan, MD MSc PhD FRCPsych
King's College London
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 27, 2023
First Posted
December 8, 2023
Study Start
November 15, 2023
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
September 9, 2025
Record last verified: 2025-03